Rajendra Singh
4PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jan 07, 2026
Population Pharmacokinetic Model-Based Dose Selection of Extended-Release Injectable Olanzapine (TV-44749) for Subcutaneous Use in Phase 3 Clinical Trial in Adults with Schizophrenia.Itay Perlstein, Irina Cherniakov, Anna Elgart
|Oct 26, 2025
Population Pharmacokinetic-Based Strategies for Switching Patients with Schizophrenia Between Long-Acting Injectable Formulations of Risperidone: R064766 or RBP-7000 to TV-46000.Itay Perlstein, Jonathan Meyer, Sharath Kumar
|Sep 08, 2025
Switching Patients with Schizophrenia from Intramuscular Paliperidone Palmitate Once Monthly to TV-46000, a Long-Acting Subcutaneous Antipsychotic: Population Pharmacokinetic-Based Strategies.Itay Perlstein, Jonathan Meyer, Ziqi Yue
|Mar 24, 2025
Population Pharmacokinetic Modeling of TV-46000, a Risperidone Long-Acting Subcutaneous Antipsychotic for the Treatment of Patients with Schizophrenia.Itay Perlstein, Avia Merenlender Wagner, Anna Elgart
Pageof 1
